SQUAMOUS CELL CARCINOMA OF THE LUNG
Clinical trials for SQUAMOUS CELL CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy targets Hard-to-Treat cancers
Disease control TerminatedThis early-phase trial tested a personalized cell therapy called ITIL-306 in people with advanced ovarian, lung, or kidney cancers that had not responded to standard treatments. The therapy uses a patient's own immune cells (TILs) taken from their tumor, modified to better attack…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LUNG
Phase: PHASE1 • Sponsor: Instil Bio • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Lung cancer biomarker study halted after enrolling only 22 patients
Knowledge-focused TerminatedThis study aimed to find genetic changes in lung tissue and blood that could predict how squamous cell lung cancer progresses. Researchers planned to collect samples from 200 patients undergoing lung procedures, but the study was stopped early with only 22 participants. No treatm…
Matched conditions: SQUAMOUS CELL CARCINOMA OF THE LUNG
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC